These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7318190)

  • 1. Failure of 2-hydroxyoestrone to lower prolactin concentrations in hyperprolactinaemic women.
    Franks S; Lightman SL; MaClusky NJ; Naftolin F; Lynch SS; Butt WR; Jacobs HS
    Clin Endocrinol (Oxf); 1981 Oct; 15(4):385-9. PubMed ID: 7318190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of phasic but not tonic pituitary secretion by 2-hydroxyoestrone in the rat: evidence of action as an oestrogen antagonist.
    Katayama S; Fishman J
    J Endocrinol; 1983 Jul; 98(1):103-12. PubMed ID: 6306131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of suppression of increased circulating prolactin by 2-hydroxyestrone.
    Kicovic PM; Franchi F; Luisi M
    Reproduccion; 1982; 6(2):113-6. PubMed ID: 7141097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen modulation of gonadotrophin and prolactin release in women with anovulation and their responses to clomiphene.
    Kandeel FR; Butt WR; Rudd BT; Lynch SS; London DR; Edwards RL
    Clin Endocrinol (Oxf); 1979 Jun; 10(6):619-35. PubMed ID: 383317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal twenty-four hour pattern of pulsatile luteinizing hormone secretion and the response to naloxone in women with hyperprolactinaemic amenorrhoea.
    Tay CC; Glasier AF; Illingworth PJ; Baird DT
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):599-606. PubMed ID: 8252751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia.
    Larrea F; Sandoval JL; Salinas E; Franco-Rodriguez VA; Méndez I; Ulloa-Aguirre A
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of prolactin and gonadotropin secretion in post-menopausal women by 2-hydroxyestrone.
    Schinfeld JS; Tulchinsky D; Schiff I; Fishman J
    J Clin Endocrinol Metab; 1980 Feb; 50(2):408-10. PubMed ID: 7354124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperprolactinaemia and female infertility.
    Godó G
    Acta Med Hung; 1984; 41(4):185-93. PubMed ID: 6440115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does 2-hydroxyestrone suppress prolactin in women?
    Merriam GR; Kono S; Loriaux DL; Lipsett MB
    J Clin Endocrinol Metab; 1982 Apr; 54(4):753-6. PubMed ID: 6801071
    [No Abstract]   [Full Text] [Related]  

  • 10. Feedback effects of steroids on gonadotrophin release in hyperprolactinaemic, ovariectomized rats.
    Carter DA; Whitehead SA
    J Endocrinol; 1981 Jun; 89(3):431-5. PubMed ID: 7252403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feedback mechanism in sulpiride-induced hyperprolactinaemia.
    Nakano R; Yagi S
    Br J Obstet Gynaecol; 1983 Apr; 90(4):350-4. PubMed ID: 6404292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of prolactin secretion by lisuride throughout the menstrual cycle and in hyperprolactinaemic menstrual disorders.
    Bohnet HG; Hanker JP; Horowski R; Wickings EJ; Schneider HP
    Acta Endocrinol (Copenh); 1979 Sep; 92(1):8-19. PubMed ID: 386688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic control of gonadotrophin secretion in normal women and in patients with pathological hyperprolactinaemia.
    Ho KY; Smythe GA; Lazarus L
    Clin Endocrinol (Oxf); 1984 Jan; 20(1):53-63. PubMed ID: 6420095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of spontaneous LH release in normo- and hyperprolactinaemic women.
    Buckman MT; Peake GT; Srivastava L
    Acta Endocrinol (Copenh); 1981 Jul; 97(3):305-10. PubMed ID: 7257698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of prolactin secretion in normal young women by 2-hydroxyestrone.
    Fishman J; Tulchinsky D
    Science; 1980 Oct; 210(4465):73-4. PubMed ID: 7414322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hyperprolactinaemia with pergolide mesylate: acute effects and preliminary evaluation of long-term treatment.
    Franks S; Horrocks PM; Lynch SS; Butt WR; London DR
    Lancet; 1981 Sep; 2(8248):659-61. PubMed ID: 6116045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary and testicular response to luteinizing hormone releasing hormone in normal and sulpiride-induced hyperprolactinaemic men.
    Nakano R; Yagi S; Nishi T
    Exp Clin Endocrinol; 1988 May; 91(2):191-6. PubMed ID: 3137082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperprolactinaemia in amenorrhoea - incidence and clinical significance.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):683-94. PubMed ID: 335758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catechol oestrogens and gonadotrophin secretion in the ewe: affinity for pituitary oestrogen receptors invitro and action on gonadotrophin secretion in vivo.
    Clarke IJ; Findlay JK
    J Endocrinol; 1980 Jun; 85(3):503-9. PubMed ID: 6774040
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulsatile gonadotrophin secretion in hyperprolactinaemic amenorrhoea an the response to bromocriptine therapy.
    Moult PJ; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1982 Feb; 16(2):153-62. PubMed ID: 6802531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.